Discordance Between aPTT and Anti-Xa in Monitoring Heparin Anticoagulation in Mechanical Circulatory Support
ESC Heart Failure · 01.10.2024 · 11 (5) · 2742-2748
DOI: 10.1002/ehf2.14816 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 09.05.2024. Verfasst von Song Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical City Healthcare, Dallas, TX, USA. Hauptthemen laut MEDLINE: Heparin, Anticoagulants, Heart-Assist Devices. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims It is unclear whether activated partial thromboplastin time (aPTT) or anti-Xa is more accurate for monitoring heparin anticoagulation in mechanical circulatory support (MCS) patients. This study investigates the relationship between aPTT and anti-Xa in MCS patients and identifies predictors of discordance. Methods and results aPTT and anti-Xa were simultaneously measured in a prospective cohort of MCS patients receiving unfractionated heparin at a tertiary academic medical centre. Therapeutic aPTT and anti-Xa levels were 60–100 s and 0.3–0.7 IU/mL, respectively, and concordance was defined as both levels being subtherapeutic, therapeutic, or supratherapeutic. To identify predictors of discordance, both a machine learning random forest model and a multivariate regression model were applied to patient demographics, device type, and 14 laboratory variables; 23 001 pairs of simultaneously measured aPTT/anti-Xa were collected from 699 MCS patients. aPTT and anti-Xa were concordant in 35.5% of paired observations and discordant in 64.5% (aPTT > antiXa 61.5%; aPTT < antiXa 3.0%). Discordance with a high aPTT relative to anti-Xa (aPTT > antiXa) was associated with high INR, eGFR, and total bilirubin, as well as low platelets, haemoglobin, pre-albumin, white blood cell count, and haptoglobin. Total artificial heart and durable ventricular assist devices were more likely to be associated with aPTT > anti-Xa than temporary MCS devices. Conclusions aPTT and anti-Xa were frequently discordant in MCS patients receiving heparin anticoagulation. Clinical conditions common in MCS patients such as concurrent warfarin use, malnutrition, haemolysis, and thrombocytopenia, as well as durable type of MCS devices were associated with a high aPTT relative to anti-Xa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical City Healthcare, Dallas, TX, USA.
- Division of Hematology & Oncology, Baylor College of Medicine, Houston, TX, USA.
- University of Washington, Seattle, WA, USA.
ORCID-Profile: Song Li
Zitieren
APA
Li, S., Li, A., Beckman, J. A., Kim, C., Granich, M. A., Mondin, J., Sabath, D. E., Garcia, D. A., & Mahr, C. (2024). Discordance Between aPTT and Anti-Xa in Monitoring Heparin Anticoagulation in Mechanical Circulatory Support. ESC Heart Failure, 11(5), 2742-2748. https://doi.org/10.1002/ehf2.14816
Vancouver
Li S, Li A, Beckman JA, Kim C, Granich MA, Mondin J, et al. Discordance Between aPTT and Anti-Xa in Monitoring Heparin Anticoagulation in Mechanical Circulatory Support. ESC Heart Failure. 2024;11(5):2742-2748. doi:10.1002/ehf2.14816
BibTeX
@article{Li2024,
author = {Li, Song and Li, Ang and Beckman, Jennifer A and Kim, Christopher and Granich, Marian A and Mondin, John and Sabath, Daniel E and Garcia, David A and Mahr, Claudius},
title = {Discordance Between aPTT and Anti-Xa in Monitoring Heparin Anticoagulation in Mechanical Circulatory Support},
journal = {ESC Heart Failure},
year = {2024},
volume = {11},
number = {5},
pages = {2742--2748},
doi = {10.1002/ehf2.14816}
}
EUVIMED